Overcoming Obstacles to Optimal Multiple Sclerosis (MS) Care in Minority Patient Populations
Program Overview
While multiple sclerosis (MS) disproportionately affects Whites of European descent, recent studies suggest an increasing rate among minority patient populations, including African and Hispanic Americans, compared to Caucasian Americans. Studies have shown ethnic differences in the characteristics, progression, and incidence of the disease, including greater disability at diagnosis and diagnostic delays compared to Caucasians. Because minority groups have been historically underrepresented in clinical trials, there has been a paucity of data in these populations. In this Clinical Transfers® activity, Drs. Mitzi Williams and Lilyana Amezcua will dive deeper into these topics, exploring the racial and ethnic variability in MS and disparities in care.
Upon completion of this activity, participants should be better able to:
Identify differences between minority patient populations and other ethnic groups with respect to multiple sclerosis (MS) symptoms, clinical course, and outcomes
Utilize strategies to address disparities in care among minority patient populations with MS
Manage minority patient populations with MS utilizing key data sets on current and emerging disease-modifying therapies
Activity Faculty
Mitzi Joi Williams, MD
Neurologist and Multiple Sclerosis Specialist Founder and Medical Director, Joi Life Wellness Group
Atlanta, GA
Lilyana Amezcua, MD, MS, FAAN
Associate Professor, Neurology Director, Multiple Sclerosis Fellowship Program
Multiple Sclerosis Comprehensive Care and Research Group
USC, Keck School of Medicine
Los Angeles, CA